Free Trial

Procter & Gamble (NYSE:PG) Trading Up 0.2%

Procter & Gamble logo with Consumer Staples background

The Procter & Gamble Company (NYSE:PG - Get Free Report)'s stock price traded up 0.2% on Tuesday . The company traded as high as $174.50 and last traded at $174.12. 1,242,317 shares changed hands during trading, a decline of 81% from the average session volume of 6,671,772 shares. The stock had previously closed at $173.77.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Procter & Gamble from $171.00 to $176.00 and gave the company a "buy" rating in a research report on Wednesday, July 17th. Dbs Bank downgraded shares of Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Thursday, August 1st. Wolfe Research raised shares of Procter & Gamble to a "strong-buy" rating in a research report on Friday, August 23rd. Royal Bank of Canada lifted their price target on Procter & Gamble from $157.00 to $164.00 and gave the company a "sector perform" rating in a research note on Wednesday, July 31st. Finally, JPMorgan Chase & Co. increased their price objective on Procter & Gamble from $179.00 to $186.00 and gave the stock an "overweight" rating in a research note on Thursday, September 19th. Eight equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $175.89.

Get Our Latest Analysis on PG

Procter & Gamble Stock Performance

The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The company has a fifty day moving average price of $170.52 and a 200 day moving average price of $165.97. The stock has a market cap of $408.87 billion, a PE ratio of 28.31, a P/E/G ratio of 3.84 and a beta of 0.41.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.37 by $0.03. The business had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company's revenue was down .1% on a year-over-year basis. During the same quarter last year, the firm earned $1.37 EPS. Analysts expect that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date of this dividend was Friday, July 19th. Procter & Gamble's payout ratio is 65.69%.

Insider Buying and Selling at Procter & Gamble

In other news, CEO Ma. Fatima Francisco sold 96,000 shares of the company's stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total value of $16,320,000.00. Following the sale, the chief executive officer now directly owns 13,721 shares of the company's stock, valued at approximately $2,332,570. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other Procter & Gamble news, CEO Ma. Fatima Francisco sold 96,000 shares of Procter & Gamble stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $170.00, for a total transaction of $16,320,000.00. Following the completion of the transaction, the chief executive officer now owns 13,721 shares in the company, valued at $2,332,570. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 3,373 shares of the stock in a transaction on Monday, August 5th. The stock was sold at an average price of $170.00, for a total value of $573,410.00. Following the completion of the sale, the chief executive officer now directly owns 21,513 shares in the company, valued at $3,657,210. The disclosure for this sale can be found here. In the last three months, insiders have sold 375,553 shares of company stock valued at $63,829,141. 0.17% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble during the 2nd quarter valued at $28,000. Fairway Wealth LLC purchased a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $29,000. Ruedi Wealth Management Inc. lifted its stake in shares of Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company's stock worth $32,000 after purchasing an additional 77 shares during the period. POM Investment Strategies LLC bought a new stake in Procter & Gamble during the second quarter valued at approximately $34,000. Finally, Transcendent Capital Group LLC purchased a new stake in Procter & Gamble during the fourth quarter valued at approximately $31,000. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

→ Don’t wait for FDA approval (From Weiss Ratings) (Ad)

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Congress Is Betting Big on Broadcom in 2024
What the Bulls and Bears Are Saying About NVIDIA Stock
Nvidia Tops Congressional Buy List

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines